|
11 |
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
Gass, Paul. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
|
|
|
|
12 |
Interest in Integrative Medicine Among Postmenopausal Hormone Receptor – Positive Breast Cancer Patients in the EvAluate-TM Study
Hack, Carolin C.. - Erlangen : Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), 2016
|
|
|
13 |
Factors Influencing Decision-Making for or against Adjuvant and Neoadjuvant Chemotherapy in Postmenopausal Hormone Receptor-Positive Breast Cancer Patients in the EvAluate-TM Study
Enthalten in Breast care Bd. 11, 2016, Nr. 5: 315-322
|
|
|
|
14 |
p16INK4A/MTS1/CDKN2 – das „Melanomgen”? Stand der Forschung und Ausblick
Enthalten in Der Hautarzt Bd. 49, Nr. 2, date:2.1998: 91-100
|
|
|
|
15 |
Influence of patient and tumor characteristics on therapy persistence with letrozole in postmenopausal women with advanced breast cancer: results of the prospective observational EvAluate-TM study
Enthalten in BMC cancer Bd. 19, 21.6.2019, Nr. 1, date:12.2019: 1-9
|
|
|
|
16 |
Widespread activation of antisense transcription of the host genome during herpes simplex virus 1 infection
Enthalten in Genome biology Bd. 18, 31.10.2017, Nr. 1, date:12.2017: 1-19
|
|
Administration
